5/13
08:21 am
bntc
Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update [Yahoo! Finance]
Medium
Report
Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update [Yahoo! Finance]
5/13
08:15 am
bntc
Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update
Medium
Report
Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update
5/1
08:08 am
bntc
Benitec Biopharma to Participate in the Citizens JMP Life Science Conference [Yahoo! Finance]
Medium
Report
Benitec Biopharma to Participate in the Citizens JMP Life Science Conference [Yahoo! Finance]
5/1
08:00 am
bntc
Benitec Biopharma to Participate in the Citizens JMP Life Science Conference
Medium
Report
Benitec Biopharma to Participate in the Citizens JMP Life Science Conference
4/22
01:22 pm
bntc
Benitec Biopharma Inc. (NASDAQ: BNTC) had its price target raised by analysts at JMP Securities from $10.00 to $16.00. They now have a "market outperform" rating on the stock.
Medium
Report
Benitec Biopharma Inc. (NASDAQ: BNTC) had its price target raised by analysts at JMP Securities from $10.00 to $16.00. They now have a "market outperform" rating on the stock.
4/18
07:39 am
bntc
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study [Yahoo! Finance]
High
Report
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study [Yahoo! Finance]
4/18
07:30 am
bntc
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study
High
Report
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study
4/18
07:23 am
bntc
Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million [Yahoo! Finance]
High
Report
Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million [Yahoo! Finance]
4/18
07:00 am
bntc
Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million
Medium
Report
Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million
4/9
08:13 am
bntc
Benitec Biopharma to Host Virtual R&D Day to Discuss BB-301 Clinical Program in Oculopharyngeal Muscular Dystrophy on April 18, 2024 [Yahoo! Finance]
Medium
Report
Benitec Biopharma to Host Virtual R&D Day to Discuss BB-301 Clinical Program in Oculopharyngeal Muscular Dystrophy on April 18, 2024 [Yahoo! Finance]
4/9
08:00 am
bntc
Benitec Biopharma to Host Virtual R&D Day to Discuss BB-301 Clinical Program in Oculopharyngeal Muscular Dystrophy on April 18, 2024
Medium
Report
Benitec Biopharma to Host Virtual R&D Day to Discuss BB-301 Clinical Program in Oculopharyngeal Muscular Dystrophy on April 18, 2024